Author: Wu Liu; Mehmet U. Caglar; Zhangming Mao; Andrew Woodman; Jamie J. Arnold; Claus O. Wilke; Craig E. Cameron
Title: More than efficacy revealed by single-cell analysis of antiviral therapeutics Document date: 2019_4_12
ID: aiyg061l_22
Snippet: of three classes of anti-PV drugs revealed three unique signatures based on changes to the 242 phenomenological parameters used to describe infection dynamics. We reasoned that PCA might 243 provide an even more robust approach to compare datasets using our five parameters. As shown 244 in Fig. 5 , PCA resolves each class of inhibitor from the other, as well as from outcomes in the 245 absence of drug. Importantly, the mechanistically related but.....
Document: of three classes of anti-PV drugs revealed three unique signatures based on changes to the 242 phenomenological parameters used to describe infection dynamics. We reasoned that PCA might 243 provide an even more robust approach to compare datasets using our five parameters. As shown 244 in Fig. 5 , PCA resolves each class of inhibitor from the other, as well as from outcomes in the 245 absence of drug. Importantly, the mechanistically related but chemically distinct inhibitors of 246 HSP90 cluster by PCA (see GA and GS in Fig. 5) . We conclude that single-cell analysis of 247 antiviral therapeutics can provide not only information on the efficacy of a drug but also 248 information on the mechanism of action. This experimental paradigm should have a 249 transformative impact on the drug-development process. 250
Search related documents:
Co phrase search for related documents- drug development and infection dynamic: 1, 2, 3
- drug development and inhibitor class: 1
- drug development process and experimental paradigm: 1
- drug development process and robust approach: 1
- drug development process and single cell: 1
- drug development process and single cell analysis: 1
- drug efficacy and infection dynamic: 1
- drug efficacy and inhibitor class: 1
- drug efficacy and single cell: 1, 2, 3
- drug efficacy and single cell analysis: 1, 2
- experimental paradigm and single cell: 1
- experimental paradigm and single cell analysis: 1
- infection dynamic and single cell: 1, 2, 3
- infection dynamic and single cell analysis: 1
- inhibitor class and single cell: 1, 2
- inhibitor class and single cell analysis: 1, 2
- robust approach and single cell: 1, 2
- single cell and unique signature: 1, 2, 3, 4, 5
Co phrase search for related documents, hyperlinks ordered by date